Company Overview and News

Govt rolls out DBT for fertiliser subsidy in 7 states/UTs

2017-10-11 thehindubusinessline
The Centre has introduced the direct benefit transfer (DBT) for fertiliser subsidies from this month in seven small states and union territories including Delhi, a senior official said today.
Upvote Downvote

Over Rs. 57,000 crore saved through direct benefit transfer

The DBT, a major reform initiative to check graft in welfare funds, was launched by the UPA on January 1, 2013.
Upvote Downvote

Over Rs 57,000 cr savings through DBT: Govt

2017-07-10 moneycontrol
The government has saved a whopping Rs 57,000 crore with its Direct Benefit Transfer (DBT) scheme under which subsidies are given directly to beneficiaries.
Upvote Downvote

Government Aims To Make India A Global Biotech Hub By 2020

2017-03-21 indiainfoline
Mr. Y. S. Chowdary, further said that - “Research and innovation has been one of the key areas emphasized by the Prime Minister. Globally, BIRAC has been hailed as one of the most effective government measures to create an enabling environment for research and development to flourish in a country. We aim to develop India into a global innovation hub by 2020 and Biotechnology Industry Research Assistance Council (BIRAC) has paved the way to deliver on that mandate.
Upvote Downvote

Introduce DBT in power distribution sector: Niti Aayog

2016-11-23 moneycontrol
It also said that in order to bring efficiency in the power distribution sector, which is largely government owned, it has to be privatised in the long term.
Upvote Downvote

Govt benefits, subsidies to be in Aadhar net now

Mumbai : The Maharashtra government on Saturday decided to push its efforts to link all direct benefit transfers (DBT) with the Aadhar Card by the end of the current calendar year. With this, all 253 state government subsidies and welfare schemes will come under the DBT net by December 31, 2016.
Upvote Downvote

Subsidies: Trapping people in a golden cage

The Government has decided to link all subsidy schemes to one Aadhar number. All subsidies such as those paid for food, LPG, MNREGA, and fertilisers will be transferred directly into the bank account linked with the Aadhar number of the beneficiary.
Upvote Downvote

Govt fixes year-end target of 100 per cent Aadhaar-linked DBT

2016-07-24 financialexpress
All Direct Benefit Transfers (DBT) will be linked to Aadhaar by the end of the current calendar year.
Upvote Downvote

As oil prices soar, here’s what’s emerged as key for India

2016-06-17 financialexpress
With the the price of oil hardening and given the pressing need to keep the momentum in public capital spending, the government is looking at plans to improve expenditure management with a sense of urgency.
Upvote Downvote

Widen scope of DBT scheme: Centre tells secretaries, states

2016-05-08 financialexpress
The Centre has asked all its departments and state governments to widen the scope of Direct Benefit Transfer scheme to include all monetary and in-kind transfers to beneficiaries, like NGOs and others assisting in implementation of the ambitious DBT programme.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...